Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-09

Clinical Trial Update: A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the addition of ipratropium to salbutamol for treatment of asthma attacks in children has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)
  • Salbutamol (salbutamol)

Snippet

Sponsor: Children's Hospital and Institute of Child Health, Multan | Conditions: Asthma Exacerbation, Children | Phase 4 | Status: COMPLETED